# Onthophagus taurus anandamide > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/onthophagus-taurus-anandamide/ > **Published:** 2026-08-26T17:30:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:42:16-04:00 > **Clinical Summary:** Explore anandamide's significance in the endocannabinoid system and its implications for cannabis-based therapies. --- ✦ New CED Clinical Relevance#67 Notable Clinical InterestEmerging findings or policy developments worth monitoring closely. NeurologyResearchMental HealthSafetyPolicyPainAnxiety Why This Matters This article matters for clinicians and their patients as it discusses Onthophagus taurus anandamide, a compound that interacts with the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/). Understanding this compound can provide insights into potential therapeutic applications, contributing to evidence-based clinical practice in managing various conditions where the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) plays a role, such as [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/) and neurodegenerative disorders. Additionally, it may contribute to the development of novel treatments derived from natural sources like Onthophagus taurus. Clinical Summary This study explores Onthophagus taurus, a beetle species, as a potential source of anandamide, a significant endocannabinoid similar to those found in cannabis. The findings suggest that this could potentially lead to alternative methods for anandamide production, which may impact the quality and accessibility of cannabis-based medications for patients. Clinicians should be aware of emerging research on non-traditional sources of endocannabinoids, as it could influence future treatment options and product standards in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) practice. Dr. Caplan’s Take “The findings on Anandamide’s potential therapeutic applications are indeed intriguing. However, it’s crucial to emphasize that while these preclinical studies offer promising insights, they primarily involve laboratory settings and not human subjects. As such, further research is necessary to validate these findings in a [clinical context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) before we can confidently integrate Anandamide into our treatment strategies.” Clinical Perspective 🔬 A recent article discusses Onthophagus taurus anandamide, a compound found in the beetle Onthophagus taurus. This endocannabinoid, similar to those produced by humans and cannabis, may have potential implications for healthcare providers. The study suggests that anandamide could potentially modulate pain and inflammation, areas of significant interest in clinical practice. However, it’s crucial to acknowledge the complexity of endocannabinoid systems and their interactions with other physiological processes. Further research is needed to fully understand the potential therapeutic applications and any associated risks or [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/). In the meantime, healthcare providers should remain informed about emerging findings in this area, as they may contribute to more effective management of pain and inflammation in the future. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Onthophagus%20taurus%20anandamide%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74905)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74905)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Onthophagus%20taurus%20anandamide%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74905)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://bf2i-arthropodacyc.insa-lyon.fr/compound?orgid=ONTTA&id=CPD-7598](https://bf2i-arthropodacyc.insa-lyon.fr/compound?orgid=ONTTA&id=CPD-7598) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).